Daehan Nupharm major shareholder side I Won-seok buys 50,000 shares in open market... stake rises to 40.85%, signaling management stability
Special relation I Won-seok acquired 50,000 shares (0.35%) of Daehan Nupharm through open market purchases from May 15 to May 27, 2026, increasing the total stake of major shareholder I Wan-jin's group from 40.5% to 40.85%.
The purchases, made at prices between 6,190 won and 6,490 won, cost approximately 315 million won and are interpreted as a move to strengthen management control.
However, the major shareholder group has pledged 1,514,537 shares (10.55%) as collateral to financial institutions, posing risks of margin calls or forced liquidation if the stock price declines.
No share buyback, cancellation, or dividend policy has been reported alongside this disclosure.
[AI Comprehensive Analysis]The increase in stake signals the major shareholder's commitment to management stability, but the high pledge ratio and modest purchase size suggest limited direct impact on stock price. Investors should monitor potential future financing needs or changes in control.